Your browser is no longer supported. Please, upgrade your browser.
Settings
ALNA Allena Pharmaceuticals, Inc. daily Stock Chart
ALNA [NASD]
Allena Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.14 Insider Own10.16% Shs Outstand17.12M Perf Week10.00%
Market Cap16.95M Forward P/E- EPS next Y-1.13 Insider Trans0.00% Shs Float- Perf Month-50.25%
Income-47.30M PEG- EPS next Q-0.48 Inst Own61.70% Short Float- Perf Quarter-55.61%
Sales- P/S- EPS this Y-24.20% Inst Trans-27.81% Short Ratio1.37 Perf Half Y-75.43%
Book/sh0.73 P/B1.36 EPS next Y4.20% ROA-102.20% Target Price9.86 Perf Year-85.86%
Cash/sh1.75 P/C0.56 EPS next 5Y- ROE-159.50% 52W Range0.52 - 7.31 Perf YTD-63.74%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-86.46% Beta-
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin- 52W Low88.57% ATR0.22
Employees40 Current Ratio3.00 Sales Q/Q- Oper. Margin- RSI (14)34.75 Volatility13.43% 23.83%
OptionableNo Debt/Eq0.58 EPS Q/Q-4.50% Profit Margin- Rel Volume1.09 Prev Close0.97
ShortableYes LT Debt/Eq0.35 EarningsMar 26 BMO Payout- Avg Volume289.27K Price0.99
Recom1.60 SMA20-21.20% SMA50-49.30% SMA200-70.20% Volume316,719 Change2.19%
Jul-10-19Resumed Credit Suisse Outperform
Jan-18-19Initiated Robert W. Baird Outperform $20
Dec-21-18Resumed B. Riley FBR Buy
Nov-08-18Resumed Jefferies Buy
Apr-25-18Initiated B. Riley FBR, Inc. Buy $23.50
Apr-02-18Initiated ROTH Capital Buy $61
Mar-18-20 12:00PM  Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why Zacks +12.15%
Mar-16-20 08:00AM  Allena Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire -37.76%
Feb-24-20 08:00AM  Allena Pharmaceuticals to Present at 40th Annual Cowen & Co. Health Care Conference GlobeNewswire
Feb-13-20 08:05AM  The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO Benzinga
Feb-12-20 07:00AM  Allena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria GlobeNewswire -5.26%
Jan-28-20 01:48PM  5 'Strong Buy' Biotech Stocks With Rapidly Approaching Catalysts Kiplinger +6.83%
Jan-14-20 12:00PM  Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why Zacks +5.35%
Dec-16-19 01:45PM  Hedge Funds Have Never Been This Bullish On Allena Pharmaceuticals, Inc. (ALNA) Insider Monkey
Dec-05-19 07:14AM  The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission Benzinga -15.58%
Dec-04-19 05:00PM  Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities GlobeNewswire
Nov-25-19 08:00AM  Allena Pharmaceuticals to Present at Evercore ISI 2nd Annual HEALTHCONx Conference GlobeNewswire
Nov-18-19 06:19AM  Do Directors Own Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares? Simply Wall St.
Nov-13-19 08:01AM  Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -8.65%
Nov-08-19 08:14AM  The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga -10.71%
Nov-07-19 06:55AM  Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206 GlobeNewswire -61.71%
Oct-17-19 08:00AM  Allena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting GlobeNewswire +9.39%
Oct-08-19 09:00AM  Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why Zacks
Sep-16-19 08:00AM  Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria GlobeNewswire
Sep-11-19 08:00AM  Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase GlobeNewswire
Aug-29-19 08:00AM  Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September GlobeNewswire
Aug-07-19 08:00AM  Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Aug-06-19 08:00AM  Allena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire +6.01%
Aug-02-19 11:46AM  Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2? Zacks
Aug-01-19 11:55AM  Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store? Zacks
Jul-31-19 09:05AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings? Zacks -6.83%
Jul-29-19 10:04AM  What's in the Cards for DaVita (DVA) This Earnings Season? Zacks
09:43AM  What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings? Zacks
Jul-26-19 10:53AM  AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing? Zacks
09:13AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings? Zacks
09:12AM  Masimo (MASI) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-25-19 07:37AM  What's in the Offing for DexCom's (DXCM) Earnings in Q2? Zacks -6.05%
Jun-27-19 08:45PM  Allena Pharmaceuticals Announces $10.0 Million Registered Direct Offering of Common Stock GlobeNewswire
Jun-21-19 08:00AM  Allena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria Workshop GlobeNewswire -5.48%
Jun-15-19 12:38PM  The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs Benzinga
Jun-04-19 08:00AM  Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders GlobeNewswire +24.38%
May-30-19 08:00AM  Allena Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference GlobeNewswire
May-08-19 09:00AM  All You Need to Know About Allena Pharmaceuticals, Inc. (ALNA) Rating Upgrade to Buy Zacks
08:00AM  Allena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Apr-17-19 09:02AM  Investors Who Bought Allena Pharmaceuticals (NASDAQ:ALNA) Shares A Year Ago Are Now Down 52% Simply Wall St.
08:01AM  Allena Pharmaceuticals Appoints Allene Diaz to its Board of Directors GlobeNewswire
Mar-27-19 08:00AM  Allena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial GlobeNewswire
Mar-07-19 08:01AM  Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update GlobeNewswire
Mar-05-19 08:00AM  Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference GlobeNewswire
Jan-04-19 08:00AM  Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019 GlobeNewswire +8.15%
Jan-02-19 08:00AM  Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria GlobeNewswire +17.98%
Dec-23-18 09:21PM  Do Hedge Funds Love Allena Pharmaceuticals, Inc. (ALNA)? Insider Monkey
Nov-19-18 08:25AM  Recent Analysis Shows Arcimoto, ADOMANI, Lipocine, Aileron Therapeutics, Allena Pharmaceuticals, and Perma-Fix Environmental Services Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -5.11%
Nov-07-18 08:00AM  Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-06-18 04:01PM  Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November GlobeNewswire
Oct-25-18 08:00AM  Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018 GlobeNewswire -5.17%
Oct-22-18 08:00AM  Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346 GlobeNewswire
Oct-18-18 08:00AM  Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings GlobeNewswire
Sep-25-18 08:00AM  Allena Pharmaceuticals to Present at Upcoming Investor Conferences in October GlobeNewswire
Aug-07-18 04:01PM  Allena Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire -6.09%
08:00AM  Allena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Jul-27-18 07:36AM  Allena Pharmaceuticals Enters Oversold Territory Zacks
Jul-12-18 07:48AM  Allena Pharmaceuticals (ALNA) Enters Oversold Territory Zacks
Jun-19-18 08:00AM  Allena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease GlobeNewswire
Jun-11-18 08:00AM  Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors GlobeNewswire
May-30-18 08:00AM  Allena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference GlobeNewswire
May-08-18 08:00AM  Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Apr-20-18 05:54PM  Allena Pharmaceuticals Inc (NASDAQ:ALNA): Are Analysts Bull Or Bear? Simply Wall St.
Apr-04-18 11:21AM  Allena Pharmaceuticals (ALNA) Enters Overbought Territory Zacks
Mar-30-18 02:31PM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Mar-27-18 08:00AM  Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update GlobeNewswire +7.68%
Mar-07-18 08:00AM  Allena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-06-18 08:00AM  Allena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria GlobeNewswire
Feb-23-18 03:03PM  Who Are The Top Investors In Allena Pharmaceuticals Inc (NASDAQ:ALNA)? Simply Wall St.
Feb-14-18 09:38PM  Pharmstandard International S.A. Buys Allena Pharmaceuticals Inc GuruFocus.com
Feb-05-18 10:00AM  Allena Pharmaceuticals, Inc. (Nasdaq: ALNA) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Nov-24-17 02:25PM  What Is The Future Prospect For Healthcare And Allena Pharmaceuticals Inc (ALNA)? Simply Wall St.
Nov-09-17 07:35PM  Allena Pharmaceuticals Inc (ALNA): Time For A Financial Health Check Simply Wall St.
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States and internationally. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases. The company was founded in 2011 and is headquartered in Newton, Massachusetts.